Your session is about to expire
← Back to Search
Dental Implant
PrimeTaper EV Implant for Missing Teeth Restoration
N/A
Waitlist Available
Led By Andy Temmerman, Prof.
Research Sponsored by Dentsply Sirona Implants
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
A stable occlusion, i.e. an opposing natural dentition, a crown, an implant-supported fixed or removable prosthesis, a partial removable prosthesis or a full denture
Adult aged 18-75 years.
Must not have
Florid infection
Hemorrhagic diathesis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at date of implant placement (anticipated average 1 month after inclusion).
Awards & highlights
No Placebo-Only Group
Summary
This trial is studying how well the PrimeTaper EV dental implant works for people who need to replace one missing tooth. The implant is placed in the jawbone and acts like a root for the new tooth. Researchers will check after some time to see if the implant is still working well.
Who is the study for?
Adults aged 18-75 needing a single tooth implant in specific positions of the jaw, with stable occlusion and adjacent teeth or crowns. Excludes those allergic to titanium/stainless steel, with uncontrolled oral diseases, bruxism, immunosuppression, recent heavy treatments (chemo/radiation), substance abuse, severe systemic diseases or conditions affecting healing.
What is being tested?
The trial is testing the PrimeTaper EV implant's success rate for single tooth restorations after one year. It aims to assess how well this particular dental implant survives and integrates into the jawbone over time.
What are the potential side effects?
While not explicitly listed in the provided information, common side effects of dental implants can include pain at the implant site, swelling of gums and face, bruising of skin and gums, minor bleeding and infection.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have stable teeth or dental work that allows me to chew properly.
Select...
I am between 18 and 75 years old.
Select...
I am between 18 and 75 years old.
Select...
My dental setup is stable with either natural teeth or dental work.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have an active, severe infection.
Select...
I have a bleeding disorder.
Select...
I am not on medications that could affect healing after surgery.
Select...
I have severe liver problems.
Select...
I am not pregnant or breastfeeding.
Select...
I do not have any health issues that could affect healing after surgery.
Select...
I need bone regeneration in the area planned for an implant.
Select...
I have had chemotherapy within the last 5 years.
Select...
I have not had a heart attack in the last 3 months.
Select...
I have or might have another type of cancer.
Select...
I do not have untreated dental issues like cavities or gum disease.
Select...
My diabetes is not well-managed.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediately after implant placement (anticipated average 1 month after inclusion).
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after implant placement (anticipated average 1 month after inclusion).
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Implant survival, i.e. number of implants in place counted clinically, 1 year after permanent restoration.
Secondary study objectives
Change of implant stability quotient value (ISQ) between implant placement and permanent restoration.
Change of marginal bone level up to 5 years post permanent restoration compared to permanent restoration.
Change of probing pocket depth (PPD) in mm between permanent restoration, and 6 months, 1, 2, 3, 4 and 5 years after permanent restoration.
+8 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Single tooth restorationsExperimental Treatment1 Intervention
A single, open-label group with patients in need of single tooth restorations will receive PrimeTaper EV implant system with diameters 3.6, 4.2, 4.8, 5.4 mm, and lengths 6.5, 8, 9, 11, 13, 15 and 17 mm.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for a partially edentulous jaw include dental implants, such as the PrimeTaper EV implant. These implants act by integrating with the jawbone through a process called osseointegration, where the titanium post of the implant fuses with the bone, providing a stable and durable foundation for single tooth restorations.
This stability is crucial for partially edentulous jaw patients as it ensures the restoration functions like a natural tooth, improving chewing efficiency, speech, and overall oral health. Additionally, implants help preserve the jawbone by preventing bone resorption that typically occurs after tooth loss.
Study of the Clinical Efficiency of an Interdisciplinary Approach to the Treatment of Orofacial Pain and Temporomandibular Joint Disorders in Patients with Complete or Partial Edentulism.Treatment planning and sequence for implant therapy in a young adult with generalized aggressive periodontitis.
Study of the Clinical Efficiency of an Interdisciplinary Approach to the Treatment of Orofacial Pain and Temporomandibular Joint Disorders in Patients with Complete or Partial Edentulism.Treatment planning and sequence for implant therapy in a young adult with generalized aggressive periodontitis.
Find a Location
Who is running the clinical trial?
Dentsply Sirona ImplantsLead Sponsor
62 Previous Clinical Trials
4,483 Total Patients Enrolled
Dentsply Sirona Implants and ConsumablesLead Sponsor
67 Previous Clinical Trials
4,760 Total Patients Enrolled
Andy Temmerman, Prof.Principal InvestigatorKU Leuven
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have an active, severe infection.I have not had radiation therapy in my head or neck area.I have not had a stroke in the last 3 months.I have a bleeding disorder.I am not on medications that could affect healing after surgery.I have severe liver problems.I am not pregnant or breastfeeding.I do not have any health issues that could affect healing after surgery.I have a tooth or implant next to the gap where my implant will go, except if it's for a first molar.I have stable teeth or dental work that allows me to chew properly.The investigator believes that your implant is stable enough to begin the study.I need bone regeneration in the area planned for an implant.I have had chemotherapy within the last 5 years.I have not had a heart attack in the last 3 months.I have or might have another type of cancer.You are willing and able to sign and date the informed consent form.I am between 18 and 75 years old.I am between 18 and 75 years old.I do not have untreated dental issues like cavities or gum disease.My diabetes is not well-managed.My dental setup is stable with either natural teeth or dental work.
Research Study Groups:
This trial has the following groups:- Group 1: Single tooth restorations
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Partially Edentulous Jaw Patient Testimony for trial: Trial Name: NCT05315414 — N/A